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Abstract
The potential use of amphiphilic fullerene derivatives as a bionanomaterial was investigated by cyclic voltammetry (CV),
scanning electron microscopy (SEM), and the ferrous ion oxidation–xylenol orange (FOX) method. Despite the disrupted
delocalization of the π-electronic system over the C60 sphere, its antioxidant capacity remained high for all twelve derivatives. The
compounds expressed up to two-fold and 5–12-fold better peroxide quenching capacity as compared to pristine C60 and standard
antioxidant vitamin C, respectively. During precipitation and slow evaporation of the solvent, all compounds underwent spontan-
eous self-assembly giving ordered structures. The size and morphology of the resulting particles depend primarily on the sample
concentration, and somewhat on the side chain structure.
Introduction
Their highly π-conjugated, spherically shaped, hydrophobic
character and their unique physicochemical, electronic and
magnetic properties make fullerenes attractive building blocks
for chemical modifications, providing at the same time novel
opportunities for developing diverse scientific fields, particu-
larly in materials science [1], supramolecular chemistry [2], and
medicinal chemistry [3,4]. The derivatization of fullerene with
peptide units substantially modifies its original properties,
rendering them particularly interesting for structural studies [5]
and biological applications [6,7]. Since the first reported syn-
thesis of a fulleropentapeptide by Prato and co-workers [8] in
1993, many examples of hybrids in this field have been
described, which has expanded research in different directions.
The functionalized fullerenes are able to self-assemble into a
plethora of supramolecular structures, such as spheres,
nanotubes, vesicles, rods, nanowires, and nanofibers [9-11].
Also, formation of diverse morphologies of self-assembled
fullerene derivatives under different external conditions has also
been the subject of interest of Nakanishi's research group
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Figure 1: Structures of studied fullereropyrrolidinic (Fp) ester 1 [24] and Fp–peptides 2–12 [27].
[12,13]. Although the morphological characterization of the
self-organized fulleropeptide nanoparticles has not been exten-
sively studied thus far, the formation of ordered superstructures
under controllable conditions through the process of self-
assembly has been observed. Here, cryo-transmission electron
microscopy [14] and SEM [15] experiments on aqueous solu-
tions of fullerene-based amino acids and peptides confirmed
their strong aggregation behavior and formation of spherical
and ellipsoidal clusters.
In the area of biological applications, a wide range of activities
of fullerene–peptide conjugates has been studied [3,7,16].
Fulleropeptides synthesized by Prato's research group [17]
showed a good bacteriostatic activity against Gram-positive
bacterium S. aureus making it interesting for potential antimi-
crobial chemotherapeutics. Recently, Keller et al. [18] reported
the synthesis of fullerenedihydropyrrole cationic peptides,
which did not show antibacterial activity. Neuroprotective and
antioxidant properties are based on the fact that fullerene
derivatives possess an extended π-bond system, with high
electron and free-radical species affinities. Water-soluble
fullerene–alanine adducts were tested as cytoprotective agents
showing high effectiveness for removing the reactive oxygen
species, such as superoxide anions and hydroxyl radicals
[19,20]. The study of the penetration of fulleropeptide nanopar-
ticles through skin represents a major contribution to the devel-
opment of carriers for biomolecules [21]. Higashi and
co-workers have reported the aggregation properties and a high
superoxide scavenging activity of fullerene–poly(Glu)peptide
nanoparticles as self-assembled structures [22]. Fullerene C60
and fulleropyrrolidine derivatives showed significant antioxi-
dant capacity to remove hydroxyl and superoxide radicals when
incorporated into liposomes [23].
With respect to the design and synthesis of fulleropyrrolidine-
based hybrids, we previously showed the synthesis of
fullerene–steroid esters [24] and triple hybrids consisting of
fullerene, peptide, and steroid units [25], which possess in vitro
antioxidant activity. Additionally, morphological characteriza-
tion of self-organized structures of fullerene–steroid [26] and
fullerene–peptide–steroid hybrids [25] in solution and in the
solid state was studied by SEM. In our previous work [27], we
described the synthesis and provided a thorough spectral char-
acterization of a series of fulleropeptide tert-butyl esters (2–12,
Figure 1) consisting of two aliphatic amino acids, γ-aminobu-
tyric acid (GABA) and glycine (Gly), using fulleropyrrolidinic
ester 1 as a starting compound. In continuation of our interest in
the chemistry of fullerene–peptide hybrids, we assumed that
their further characterization could contribute to a better under-
standing of the synergy of the molecular subunits, as well as to
potential applications in the field of new bionanomaterials.
Consequently, here we present the results of the electrochem-
ical, in vitro antioxidant and morphological investigations of
compounds 1–12.
Results and Discussion
Cyclic voltammetry (CV) of fullerene derivatives plays a rele-
vant role in the characterization of their electronic properties
and potential applications [28]. The electrochemical investi-
gation of fulleropyrrolidine esters 1–12 by CV was carried out
in dimethylformamide (DMF) at room temperature with tetra-
butylammonium perchorate (TBAP) as the supporting elec-
trolyte and a ferrocene/ferrocenyl couple (Fc/Fc+) as the
internal redox standard. The observed half-wave reduction
potentials (E1/2) of the studied compounds together with those
of pristine C60 (as a reference compound [29]) are listed in
Table 1.
The voltammetric behavior of the compounds is characterized
by the presence of four reversible, one-electron reductions, all
attributable to the 58 member π-electron system of fulleropyrro-
lidinic subunit, similar to that found for other fulleropyrolidine
monoadducts [30]. As a consequence of the fullerene [6,6]-
double bond saturation (after Prato's reaction), all four
registered half-wave potentials were cathodically shifted by
110–240 mV relative to pristine C60, and appeared at approxi-
mately −1.0, −1.4, −2.0, and −2.6 V vs Fc/Fc+ (1st to 4th, res-
pectively).
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Table 1: Half-wave reduction potentials vs Fc/Fc+ (0.53 V vs Ag/Ag+ in
DMF) of fullerene esters in DMF containing 0.1 M TBAP as the
supporting electrolyte.
Compound E1/2 (V)
1st 2nd 3rd 4th
1 −0.94 −1.40 −2.06 −2.57
2 −0.94 −1.39 −2.05 −2.59
3 −1.01 −1.39 −2.06 −2.58
4 −0.99 −1.38 −2.04 −2.58
5 −0.92 −1.38 −2.08 −2.60
6 −0.98 −1.40 −2.06 −2.60
7 −0.94 −1.39 −2.06 −2.62
8 −0.99 −1.38 −2.04 −2.57
9 −0.98 −1.36 −2.02 −2.52
10 −0.94 −1.39 −2.04 −2.54
11 −1.00 −1.39 −2.03 −2.56
12 −0.96 −1.39 −2.07 −2.61
C60a −0.77 −1.25 −1.84 −2.38
aHalf-wave reduction potentials from [27] and recalculated according to
the Fc/Fc+ value.
Although the fullerene functionalization resulted in the decrease
of the electron affinity, the π-electron system was not dramati-
cally disrupted, thus, it could be expected that the carbon core
in the studied compounds retained its antioxidant capacity. The
antioxidant activity of 12 fullerene esters (as water soluble
fullerosomes, obtained by liposome formation with soybean
lecithin [31]) was determined by FOX antioxidant assay [32],
using vitamin C and fullerene C60 as reference compounds. The
FOX assay is based on the oxidation of ferrous to ferric ions in
the presence of hydroperoxides in acidic media and subsequent
complex formation with xylenol orange (XO), monitored using
spectrophotometry by measuring the absorbance at 560 nm
(A560). In the presence of an antioxidant compound, the A560
decreases due to hydroperoxide quenching. The antioxidant
capacity of the compounds studied, expressed as an inhibitory
effect toward oxidation, was evaluated by monitoring the for-
mation of an Fe3+–XO complex. The experiments were
performed by incubating the aqueous solution of tert-butyl
hydroperoxide (TBHP), tested compounds (0.002 mg/mL) and
FOX reagent, followed by the A560 measurement. The results of
the direct antioxidant capacity are expressed as the percentage
of consumed TBHP (Δ%) (see Experimental section, Table 2),
demonstrating the level of peroxide consumed. Recalculations
provided results of molar activities and expressing them in com-
parison to vitamin C afforded values of the relative antioxidant
activity (Aox-rel), as presented in Figure 2. As can be seen, the
fullerene esters showed much higher capability to decrease the
level of peroxides in solution compared to the standard antioxi-
dant agent, vitamin C. All the tested fullerene esters expressed
five- to twelve-fold higher antioxidant capacity compared to
vitamin C, and similarly to C60 (compound 6) with an up to
two-fold better performance. It was shown that derivatization of
fullerenes with peptide units enhances their solubility [27] and,
consequently, their essential antioxidant capacity, which is
mainly attributed to the electron-accepting properties of the
fullerene unit.
Figure 2: Comparison of the relative antioxidant activities (Aox-rel) of
the tested compounds (1–12) and C60 with regard to vitamin C
(Aox-rel = 1) measured by FOX assay.
The self-assembly characteristics of fulleropeptide esters 2–12
were studied by SEM on the samples prepared by a drop–drying
process [2] and on the solid samples. In order to examine the
influence of the peptide chain on the self-assembly properties,
the aggregation behavior of the parent Fp–GABA ester 1 (the
control compound without the peptide moiety) was also
included in this investigation. The SEM study on the control
compound was reported and showed that the best-ordered, self-
organized structures are obtained in a binary solvent mixture,
5:1 PhMe/MeOH [25]. The morphological features of each of
the tested fullerene derivatives were investigated under the
same conditions, using dried samples obtained from dilute solu-
tions by slow evaporation in a 5:1 PhMe/MeOH mixture
(10 µL, 1 mM) on a Si substrate at room temperature. The ester
1 arranged into a flower-shaped, hierarchically ordered architec-
ture of curled leaf-like particles with diameters of up to 5 μm
(Figure 3A) [25]. Figure 3B–F shows selected representative
examples of SEM micrographs of typical fulleropeptide self-
assembled structures. Additionally, SEM images of self-orga-
nized structures of all the investigated compounds are shown in
Figure S1 (Supporting Information File 1). Two types of
rounded particles (flat and curled), originating from spontan-
eously formed, self-organized spherical nanoparticles, were the
dominant structures observed among all the investigated
fulleropeptides (Figure 3).
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Figure 3: Selected SEM images of flower-shaped, self-organized particles of the parent ester 1 (A), and different fulleropeptide self-assemblies.
(B) Isolated, curled microsheets of 6. (C, D) Isolated, flat, spherical particles of 4 and 11. (E, F) Networks of spherical particles of 9 and 12, all
prepared from 5:1 PhMe/MeOH (v/v) on a Si substrate after evaporation of a 1 mM solution. Scale bars correspond to 5 μm.
The examined GABA containing homopeptides 2 and 3, tripep-
tide 7, and the tetrapeptides 6, 8, and 10 all prefer to form
similar isolated, curled microparticles as final assemblies with
dimensions up to 3 μm (Figure 3B (6)). SEM studies revealed
that the other five fulleropeptides, 4, 5, 9, 11, and 12, self-
assembled into mainly individual, flat-spherical nanoparticles of
various sizes (Figure 3C,D) or into the network-type structures
(Figure 3E,F). It should be noted that the heteropeptides 9, 11,
and 12 had the increased tendency to form fused or stacked
small spherical particles with a flat morphology, giving
branched, straight aggregates as the start of network formation
(Figure 3E, fulleropeptide 9), and finally, a complete network of
spherical particles (fulleropeptide 12 at a five-fold higher
concentration, Figure 3F). Additionally, SEM micrographs
(Supporting Information File 1, Figure S1, insets) have clearly
revealed network-like structures of three fulleropeptide esters,
9, 11, and 12, obtained at this concentration, indicating the
morphology dependence of the investigated compounds on the
peptide concentration. It was shown that the longer peptide
chain facilitates the formation of a network structure as a conse-
quence of stronger, arranged interparticle associations. The
solid samples of the control compound 1, obtained by precipita-
tion from a CHCl3/CS2 solution with solvents of different
polarity (i.e., MeOH, Et2O or hexane, on a brass substrate),
gave well-organized particles only with the polar solvent,
MeOH, indicating an influence of hydrogen bond formation on
self-assembly even during fast aggregation. Compared with the
randomly scattered, rod-like, self-organized particles of
Fp–GABA ester 1 (Figure 4A, with lengths up to 9 μm), the
representative SEM images of the solid samples of all the
investigated derivatives (Figure 4) revealed very large, hierar-
chically arranged, supramolecular, round-shaped assemblies of
leafy structures, with diameters ranging from 1 to 15 μm in the
form of: flowers (Figure 4B, 5, ≈7 μm), spiral objects
(Figure 4C, 8, ≈15 μm), and artichoke-shaped objects
(Figure 4D, 10, ≈15 μm). The SEM images of all the investi-
gated solid samples are presented in Supporting Information
File 1, Figure S2.
Figure 4: Representatives of the SEM images of the self-organized
rods of Fp–GABA ester 1 (A) and fulleropeptides self-assembled parti-
cles: flower (B, 5), spiral-shaped object (C, 8), and artichoke-shaped
object (D, 10) prepared from the solid samples deposited on a brass
substrate. Scale bars correspond to 10 μm.
The morphological differences of the self-organized fulleropep-
tide particles and the control compound without the peptide
moiety studied here, demonstrate the influence of hydrogen
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bonds and van der Waals interactions associated with the
peptide moiety. This, together with the intermolecular, non-
covalent π–π interactions of the fullerene moiety, affects the
supramolecular cohesion of fulleropeptide assemblies. The
proposed self-assembly path of amphiphilic fulleropeptide
esters into spherical particles, their gradual growth to rods or
curled leaves, and the final network and artichoke-shaped
microstructures are shown in Figure 5.
Figure 5: Schematic illustration of the proposed formation of different
self-assembled microstructures starting from the fulleropeptide spher-
ical nanoparticles.
Conclusion
The present study could contribute to the further exploration of
fulleropeptide esters as self-assembled materials with antioxi-
dant properties. In summary, we have investigated the influ-
ence of structurally different subunits on the electrochemical,
morphological, and antioxidant properties of previously synthe-
sized fullerene–peptide hybrids. Fulleropeptide esters and non-
peptidic fulleropyrrolidine showed mutually, almost identical
electrochemical properties with decreased electronegativity in
comparison to C60. Its hydroperoxide quenching activity for the
studied amphiphilic derivatives also remained high. A prelimi-
nary in vitro study of the antioxidant efficiency of 12 liposomal
fullerene esters, examined by the FOX method, confirmed their
much higher antioxidant activity (up to 12-fold) relative to
vitamin C. Also, despite the disruption of the π-electron system
over a fullerene subunit upon functionalization, similar activity
(up to twice better) in relation to C60 was reached. Besides im-
proved solubility and high antioxidant capacity, amphiphilic
fulleropeptide esters expressed good self-assembly properties,
giving ordered structures during both fast aggregation and slow
evaporation of the appropriate solvent. In contrast to the rod-
like particles of non-peptidic ester 1, solid samples of
fulleropeptides generated different, hierarchical, highly orga-
nized assemblies such as flower-like, artichoke-like and spiral
objects. During the slow evaporation of the solvent, all com-
pounds, regardless of the number of peptide bonds, spontan-
eously formed morphologically similar nano- and micro-scale
spherical particles, which further assembled into hierarchically
more- or less-ordered architectures, resembling circles or
networks. Also, the morphology variation ranging from indi-
vidual spherical to network self-assemblies was achieved by a
five-fold concentration increase.
Experimental
The fullerene–peptide derivatives 2–12 were synthesized
according to the literature procedure [27]. The solvents (HPLC
grade) used for the CV and SEM experiments were stored over
3 Å molecular sieves and degassed under vacuum prior to use.
Ferrocene (Fc) and tetrabutylammonium perchlorate (TBAP)
were purchased from Sigma-Aldrich and used as received.
Cyclic voltammetry
The electrochemical behavior of the fullerene esters was
investigated using a 1 mM solution in dry DMF, containing
0.1 M TBAP as the supporting electrolyte, in a similar manner
to that previously described in [33]. In order to remove oxygen
from the electrolyte, the system was bubbled with argon prior to
each experiment and the gas remained above the liquid surface
during the scans. The electrochemical measurements were
carried out on a CHI760b Electrochemical Workstation poten-
tiostat (CH Instruments, Austin, TX) by using a conventional
three-electrode cell (5 cm3) equipped with a glassy carbon elec-
trode, a silver wire (Ag/Ag+) (in contact with 0.01 M AgNO3
and 0.10 M TBAP in acetonitrile) and a platinum wire as the
working, reference and auxiliary electrodes, respectively, cali-
brated with a ferrocene/ferrocenyl couple (Fc/Fc+) as an internal
standard. All experiments were performed at room temperature
in the potential range of −3.0 to 0.6 V vs saturated calomel elec-
trode (SCE), with sweep rates between 0.01 and 1 Vs−1.
Scanning electron microscopy
Investigations of sample morphology were carried out with
SEM, using a JEOL JSM-840A instrument, at an acceleration
voltage of 30 kV. The solid samples were prepared by precipita-
tion from a CHCl3/CS2 solution with solvents of different
polarity (i.e., MeOH, Et2O or hexane), and subsequent drying
under vacuum. A small amount of each compound was
dispersed on a brass substrate. The dried samples obtained from
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dilute solutions were prepared as follows: 10 μL of 1 mM
solution in the PhMe/MeOH (5:1, v/v) mixture of fullerene
derivatives was deposited on the surface of a Si substrate
(10 × 10 mm) and left overnight to slowly evaporate in a glass
petri dish (diameter 10 cm) under PhMe atmosphere at room
temperature. Additionally, compounds 9, 11, and 12 were
prepared in the same solvent system at higher concentration
(50 µL of 1 mM solution). The investigated samples were gold
sputtered in a JFC 1100 ion sputter device and then subjected to
SEM observations.
In vitro antioxidant activity
The antioxidant activity was determined according to the FOX
method [30]. The working FOX reagent was prepared as previ-
ously described [25]. The reagent was used within 24 h. The
absorbance of the Fe3+–XO complex was measured at 560 nm
by UV–vis spectrophotometry (GBC-Cintra 40) with 90%
MeOH as a zero probe. The detailed procedure of the fullero-
some preparation of the tested compound and soybean lecithin
in a 1:4 ratio is described in our previous work [25]. The final
concentration of the pure 0.002 mg/mL compound was obtained
prior to use. The same volume of 200 μM TBHP (obtained by
diluting 0.050 mL of 2 mM TBHP with 0.450 mL of H2O) was
added to the sample and vortexed for 1 min. After 10 min of
incubation at room temperature, 0.950 mL of FOX reagent was
added to an aliquot of 0.050 mL of the sample. The absorbance
at 560 nm was determined for each sample after 80 min of incu-
bation at room temperature. The starting probe of TBHP was
prepared in the same manner, replacing the sample by the same
volume of H2O. The absorbance of the starting probe refers to
the starting (maximum) concentration of the peroxide in sample
solution, prior to incubation. The difference in the absorbance
of the starting probe (As) and the sample (A) is proportional to
the quantity of the peroxide consumed by the sample com-
pound. The blank probe contained 0.950 mL of FOX reagent
and 0.050 mL of H2O. The absorbance of the blank probe
measured at 560 nm (A0) refers to the colour of the reagent
itself in the absence of the peroxide, and all sample and stan-
dard absorbance results are normalized by the value of A0 in the
peroxide concentration calculations.
The applicability of the method for use in the range of peroxide
concentrations given was confirmed by preparing a standard
calibration curve using increasing concentrations of TBHP
(0–200 μM) incubated with FOX reagent at room temperature
for 30 min. There is a linear relationship between the 560 nm
absorbance measurements and the different concentrations of
TBHP. All experiments were performed in triplicate, and the
average values were taken. The calculation of the direct antioxi-
dant capacity, given as the percentage of consumed TBHP
(Δ%), was performed using the following equation:
(1)
where A, As and A0 represent the absorbance of the tested com-
pound, starting probe (TBHP+FOX) and blank (FOX) probe,
respectively. In addition, the relative molar antioxidant capaci-
ties (Aox-rel) of the tested compounds relative to vitamin C are
summarized in Table 2.
Table 2: The direct antioxidant capacity (Δ%) and the relative antioxi-
dant capacity (Aox-rel) of the tested compounds (0.002 mg/mL) rela-
















Vitamin C −11.7 1
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